-
1
-
-
0029582820
-
-
T. Schilling, B. K. Keppler, M. E. Heim, G. Niebch, H. Dietzfelbinger, J. Rastetter, A. R. Hanauske, Invest. New Drugs 1996, 13, 327-332.
-
(1996)
Invest. New Drugs
, vol.13
, pp. 327-332
-
-
Schilling, T.1
Keppler, B.K.2
Heim, M.E.3
Niebch, G.4
Dietzfelbinger, H.5
Rastetter, J.6
Hanauske, A.R.7
-
4
-
-
0031661569
-
-
G. Lummen, H. Sperling, H. Luboldt, T. Otto, H. Rubben, Cancer Chemother. Pharmacol. 1998, 42, 415-417.
-
(1998)
Cancer Chemother. Pharmacol
, vol.42
, pp. 415-417
-
-
Lummen, G.1
Sperling, H.2
Luboldt, H.3
Otto, T.4
Rubben, H.5
-
5
-
-
0342948839
-
-
N. Kröger, U. R. Kleeberg, K. Mross, L. Edler, G. Saß, D. Hossfeld, Onkologie 2000, 23, 60-62.
-
(2000)
Onkologie
, vol.23
, pp. 60-62
-
-
Kröger, N.1
Kleeberg, U.R.2
Mross, K.3
Edler, L.4
Saß, G.5
Hossfeld, D.6
-
6
-
-
0942266508
-
-
O. R. Allen, L. Croll, A. L. Gott, R. J. Knox, P. C. McGowan, Organometallics 2004, 23, 288-292.
-
(2004)
Organometallics
, vol.23
, pp. 288-292
-
-
Allen, O.R.1
Croll, L.2
Gott, A.L.3
Knox, R.J.4
McGowan, P.C.5
-
8
-
-
26444498512
-
-
N. J. Sweeney, O. Mendoza, H. Müller-Bunz, C. Pampillón, F.-J. K. Rehmann, K. Strohfeldt, M. Tacke, J. Organomet. Chem. 2005, 690, 4537-4544.
-
(2005)
J. Organomet. Chem
, vol.690
, pp. 4537-4544
-
-
Sweeney, N.J.1
Mendoza, O.2
Müller-Bunz, H.3
Pampillón, C.4
Rehmann, F.-J.K.5
Strohfeldt, K.6
Tacke, M.7
-
9
-
-
27644514186
-
-
G. Kelter, N. J. Sweeney, K. Strohfeldt, H.-H. Fiebig, M. Tacke, Anti-Cancer Drugs 2005, 16, 1091-1098.
-
(2005)
Anti-Cancer Drugs
, vol.16
, pp. 1091-1098
-
-
Kelter, G.1
Sweeney, N.J.2
Strohfeldt, K.3
Fiebig, H.-H.4
Tacke, M.5
-
10
-
-
27644536324
-
-
O. Oberschmidt, A. R. Hanauske, F.-J. K. Rehmann, K. Strohfeldt, N. J. Sweeney, M. Tacke, Anti-Cancer Drugs 2005, 16, 1071-1073.
-
(2005)
Anti-Cancer Drugs
, vol.16
, pp. 1071-1073
-
-
Oberschmidt, O.1
Hanauske, A.R.2
Rehmann, F.-J.K.3
Strohfeldt, K.4
Sweeney, N.J.5
Tacke, M.6
-
11
-
-
33846658635
-
-
O. Oberschmidt, A. R. Hanauske, C. Pampillón, N. J. Sweeney, K. Strohfeldt, M. Tacke, Anti-Cancer Drugs 2007, 18, 317-321.
-
(2007)
Anti-Cancer Drugs
, vol.18
, pp. 317-321
-
-
Oberschmidt, O.1
Hanauske, A.R.2
Pampillón, C.3
Sweeney, N.J.4
Strohfeldt, K.5
Tacke, M.6
-
12
-
-
33745806258
-
-
K. O'Connor, C. Gill, M. Tacke, F.-J. K. Rehmann, K. Strohfeldt, N. Sweeney, J. M. Fitzpatrick, R. W. G. Watson, Apoptosis 2006, 11, 1205-1214.
-
(2006)
Apoptosis
, vol.11
, pp. 1205-1214
-
-
O'Connor, K.1
Gill, C.2
Tacke, M.3
Rehmann, F.-J.K.4
Strohfeldt, K.5
Sweeney, N.6
Fitzpatrick, J.M.7
Watson, R.W.G.8
-
13
-
-
33644987817
-
-
M. C. Valaderes, A. L. Ramos, F.-J. K. Rehmann, N. J. Sweeney, K. Strohfeldt, M. Tacke, M. L. S. Queiroz, Eur. J. Pharmacol. 2006, 534, 264-270.
-
(2006)
Eur. J. Pharmacol
, vol.534
, pp. 264-270
-
-
Valaderes, M.C.1
Ramos, A.L.2
Rehmann, F.-J.K.3
Sweeney, N.J.4
Strohfeldt, K.5
Tacke, M.6
Queiroz, M.L.S.7
-
14
-
-
33646089648
-
-
I. Fichtner, C. Pampillón, N. J. Sweeney, K. Strohfeldt, M. Tacke, Anti-Cancer Drugs 2006, 17, 333-336.
-
(2006)
Anti-Cancer Drugs
, vol.17
, pp. 333-336
-
-
Fichtner, I.1
Pampillón, C.2
Sweeney, N.J.3
Strohfeldt, K.4
Tacke, M.5
-
15
-
-
33846706066
-
-
P. Beckhove, O. Oberschmidt, A. R. Hanauske, C. Pampillón, V. Schirrmacher, N. J. Sweeney, K. Strohfeldt, M. Tacke, Anti-Cancer Drugs 2007, 18, 311-315.
-
(2007)
Anti-Cancer Drugs
, vol.18
, pp. 311-315
-
-
Beckhove, P.1
Oberschmidt, O.2
Hanauske, A.R.3
Pampillón, C.4
Schirrmacher, V.5
Sweeney, N.J.6
Strohfeldt, K.7
Tacke, M.8
-
16
-
-
47649112500
-
-
J. Claffey, M. Hogan, H. Müller-Bunz, C. Pampillón, M. Tacke, ChemMedChem 2008, 3, 729-731.
-
(2008)
ChemMedChem
, vol.3
, pp. 729-731
-
-
Claffey, J.1
Hogan, M.2
Müller-Bunz, H.3
Pampillón, C.4
Tacke, M.5
-
20
-
-
34548602015
-
-
F. Caruso, Inorg. Chem. 2007, 46, 7553-7560.
-
(2007)
Inorg. Chem
, vol.46
, pp. 7553-7560
-
-
Caruso, F.1
-
21
-
-
85153218221
-
-
G. M. Sheldrick, SADABS Version 2.03, University of Göttingen, Germany, 2002
-
G. M. Sheldrick, SADABS Version 2.03, University of Göttingen, Germany, 2002.
-
-
-
|